56 related articles for article (PubMed ID: 9627111)
21. Advances in the development of ribozymes and antisense oligodeoxynucleotides as antiviral agents for human papillomaviruses.
Alvarez-Salas LM; Benítez-Hess ML; DiPaolo JA
Antivir Ther; 2003 Aug; 8(4):265-78. PubMed ID: 14518695
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of human papillomavirus-consensus primers for HPV detection by the polymerase chain reaction.
Harnish DG; Belland LM; Scheid EE; Rohan TE
Mol Cell Probes; 1999 Feb; 13(1):9-21. PubMed ID: 10024428
[TBL] [Abstract][Full Text] [Related]
23. Molecular mechanisms in progression of HPV-associated cervical carcinogenesis.
Gupta SM; Mania-Pramanik J
J Biomed Sci; 2019 Apr; 26(1):28. PubMed ID: 31014351
[TBL] [Abstract][Full Text] [Related]
24. A quantitative approach to the loss of heterozygosity in p53 allele on detection of human cervical cancer using a BioImaging Analyzer.
Kinoshita M; Shin S; Hirao T; Aono T
Asia Oceania J Obstet Gynaecol; 1994 Mar; 20(1):87-92. PubMed ID: 8172533
[TBL] [Abstract][Full Text] [Related]
25. Expression pattern of the PRDX2, RAB1A, RAB1B, RAB5A and RAB25 genes in normal and cancer cervical tissues.
Nikoshkov A; Broliden K; Attarha S; Sviatoha V; Hellström AC; Mints M; Andersson S
Int J Oncol; 2015 Jan; 46(1):107-12. PubMed ID: 25339198
[TBL] [Abstract][Full Text] [Related]
26. Identification of two novel cellular genes associated with multistage carcinogenesis of human endocervical cells by mRNA differential display.
Yang X; Nakao Y; Pater MM; Pater A
Carcinogenesis; 1996 Mar; 17(3):563-7. PubMed ID: 8631146
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic regulation of gene expression in cervical cancer cells by the tumor microenvironment.
Denko N; Schindler C; Koong A; Laderoute K; Green C; Giaccia A
Clin Cancer Res; 2000 Feb; 6(2):480-7. PubMed ID: 10690527
[TBL] [Abstract][Full Text] [Related]
28. Modeling the dynamics of chromosomal alteration progression in cervical cancer: A computational model.
Cabrera-Becerril A; Vargas-De-León C; Hernández S; Miramontes P; Peralta R
PLoS One; 2017; 12(7):e0180882. PubMed ID: 28723940
[TBL] [Abstract][Full Text] [Related]
29. Antagonism of 2 virus-infections in the development of cervical-cancer - (review - hypothesis).
Rabreau M; Schlehofer J
Oncol Rep; 1995 Jan; 2(1):95-7. PubMed ID: 21597697
[TBL] [Abstract][Full Text] [Related]
30. TSPAN1: A Novel Protein Involved in Head and Neck Squamous Cell Carcinoma Chemoresistance.
Garcia-Mayea Y; Mir C; Carballo L; Castellvi J; Temprana-Salvador J; Lorente J; Benavente S; García-Pedrero JM; Allonca E; Rodrigo JP; LLeonart ME
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33167355
[TBL] [Abstract][Full Text] [Related]
31. The cancer-associated cell migration protein TSPAN1 is under control of androgens and its upregulation increases prostate cancer cell migration.
Munkley J; McClurg UL; Livermore KE; Ehrmann I; Knight B; Mccullagh P; Mcgrath J; Crundwell M; Harries LW; Leung HY; Mills IG; Robson CN; Rajan P; Elliott DJ
Sci Rep; 2017 Jul; 7(1):5249. PubMed ID: 28701765
[TBL] [Abstract][Full Text] [Related]
32. Genome wide expression analysis in HPV16 cervical cancer: identification of altered metabolic pathways.
Pérez-Plasencia C; Vázquez-Ortiz G; López-Romero R; Piña-Sanchez P; Moreno J; Salcedo M
Infect Agent Cancer; 2007 Sep; 2():16. PubMed ID: 17822553
[TBL] [Abstract][Full Text] [Related]
33. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.
Nees M; Geoghegan JM; Hyman T; Frank S; Miller L; Woodworth CD
J Virol; 2001 May; 75(9):4283-96. PubMed ID: 11287578
[TBL] [Abstract][Full Text] [Related]
34. [Global expression analysis in uterine cervical cancer: metabolic pathways and altered genes].
Vázquez-Ortíz G; Piña-Sanchez P; Hidalgo A; Lazos M; Moreno J; Alvarado I; Cruz F; Hernández DM; Pérez-Plascencia C; Salcedo M
Rev Invest Clin; 2005; 57(3):434-41. PubMed ID: 16187704
[TBL] [Abstract][Full Text] [Related]
35. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F
Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059
[TBL] [Abstract][Full Text] [Related]
36. Changes in cervical keratinocyte gene expression associated with integration of human papillomavirus 16.
Alazawi W; Pett M; Arch B; Scott L; Freeman T; Stanley MA; Coleman N
Cancer Res; 2002 Dec; 62(23):6959-65. PubMed ID: 12460913
[TBL] [Abstract][Full Text] [Related]
37. HPV induced cervical carcinogenesis: molecular basis and vaccine development.
Kaufmann AM; Backsch C; Schneider A; Dürst M
Zentralbl Gynakol; 2002 Nov; 124(11):511-24. PubMed ID: 12796844
[TBL] [Abstract][Full Text] [Related]
38. Biology and pathological associations of the human papillomaviruses: a review.
Cheah PL; Looi LM
Malays J Pathol; 1998 Jun; 20(1):1-10. PubMed ID: 10879257
[TBL] [Abstract][Full Text] [Related]
39. Identification of novel molecular markers which correlate with HPV-induced tumor progression.
Nees M; van Wijngaarden E; Bakos E; Schneider A; Dürst M
Oncogene; 1998 May; 16(19):2447-58. PubMed ID: 9627111
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
